C. Martin Curtis
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Bo MaRichard KeffordGeorgina V. LongPeter F. LebowitzSteven O’DayAnna C. PavlickGerald S. FalchookJeffrey R. Infante
- Topics
- Melanoma and MAPK Pathways (8 papers)Lung Cancer Treatments and Mutations (5 papers)Synthesis and biological activity (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
C. Martin Curtis
18 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 952
- Oncology 865
- Pulmonary and Respiratory Medicine 624
- Cancer Research 280
- Pathology and Forensic Medicine 262
Countries citing papers authored by C. Martin Curtis
This map shows the geographic impact of C. Martin Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Martin Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Martin Curtis more than expected).
Fields of papers citing papers by C. Martin Curtis
This network shows the impact of papers produced by C. Martin Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Martin Curtis. The network helps show where C. Martin Curtis may publish in the future.
Co-authorship network of co-authors of C. Martin Curtis
This figure shows the co-authorship network connecting the top 25 collaborators of C. Martin Curtis. A scholar is included among the top collaborators of C. Martin Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Martin Curtis. C. Martin Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialbreakdown → | 334 |
| 3 | Test-retest analysis of a non-invasive method of quantifying [C-11]-PBR28 binding in Alzheimer's disease | 17 |
| 4 | 24 | |
| 5 | 51 | |
| 6 | 20 | |
| 7 | 9 | |
| 8 | 91 | |
| 9 | 76 | |
| 10 | 36 | |
| 11 | Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialbreakdown → | 719 |
| 12 | 29 | |
| 13 | 73 | |
| 14 | 19 | |
| 15 | 3 | |
| 16 | 12 | |
| 17 | 14 | |
| 18 | 86 |
About C. Martin Curtis
C. Martin Curtis is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Oncology (865 citations), Pulmonary and Respiratory Medicine (624 citations) and Cancer Research (280 citations). C. Martin Curtis has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Bo Ma, Richard Kefford, Georgina V. Long, Peter F. Lebowitz, Steven O’Day, Anna C. Pavlick, Gerald S. Falchook, Jeffrey R. Infante, Michael Millward and Michael P. Brown. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.